ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Approves 127 Cancer Programs; Total Now 994

March 18, 1983

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Cancer Survival Now May Be Well Over 50 Percent, ACS President Says; Cigarette Consumption Drops

April 6, 1984

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

When Doctors Take Work Home: Houston Burglary Points to Security Breach

June 29, 2012

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977